If Hairgenetix doesn’t deliver results in 4 months, get a full refund in just 3 simple steps.
Trusted by hundreds and rated
With an 'Excellent' rating of 4.6 stars, based on over 1,200 reviews, our customers' trust in Hairgenetix reflects the remarkable results you can achieve with our hair growth products.
Our products are third-party clinically tested
In a 150-day clinical trial involving 30 men and women aged 18–65 with diverse types of hair loss, the Hairgenetix serum achieved a clinically proven 93% reduction in hair shedding.
GHK-Cu: The Science Behind Copper Peptide Hair Regeneration (2018 Review)
Posted by Loren Pickart, Anna Margolina on March 05, 2026
Key Findings at a Glance
GHK-Cu is a naturally occurring human peptide that influences 31.2% of all human genes — resetting gene expression toward a healthier, younger state. It stimulates collagen synthesis (up to 70% increase), promotes blood vessel growth, and accelerates wound healing. Your body naturally produces GHK-Cu, but levels decline by 60% between age 20 and age 60 (from 200 ng/mL to 80 ng/mL). Gene data analysis shows GHK-Cu upregulates tissue repair genes and downregulates 70% of cancer-related genes. The review cites evidence that GHK-Cu's hair-stimulating effects appear comparable to 2% minoxidil — with a superior safety profile.
Research Evidence Summary
Scope
Comprehensive review of GHK-Cu regenerative and protective actions
This article is a plain-language summary of a peer-reviewed scientific review. It is intended to make clinical research more accessible and is not medical advice. Always consult a qualified healthcare professional before starting any new treatment. The original review was conducted independently and is not affiliated with Hairgenetix.
Reviewed by: Esther Bodde — Cosmetic & Medical Doctor (MD)
Why This Research Matters
GHK-Cu is not just a cosmetic ingredient — it is a naturally occurring molecule in your own body that declines significantly as you age. This 2018 review by Loren Pickart (who originally discovered GHK-Cu in the 1970s) and Anna Margolina brings together decades of research and adds groundbreaking gene expression analysis showing that GHK-Cu affects nearly a third of all human genes.
For hair loss specifically, this matters because GHK-Cu acts on the same biological pathways involved in follicle health: collagen synthesis, blood vessel formation, wound healing, stem cell signalling, and cell survival. Unlike most hair treatments that target a single mechanism, GHK-Cu operates across multiple regenerative systems simultaneously — which is why it has attracted interest from dermatologists, cosmetic chemists, and hair loss researchers worldwide.
This review is also significant because it positions GHK-Cu in the context of gene data from the Broad Institute's Connectivity Map — the same database used by pharmaceutical researchers to discover new drug applications. The gene analysis reveals that GHK-Cu doesn't just treat symptoms; it shifts gene expression patterns toward a younger, healthier state.
What The Researchers Reviewed
Pickart and Margolina conducted a comprehensive review covering three decades of GHK-Cu research. Their analysis included:
1. Historical research on GHK-Cu's biological functions
The review consolidates findings from laboratory studies, animal models, and human clinical trials spanning from the 1980s to 2018. This includes wound healing trials, skin rejuvenation studies, and tissue repair research across multiple organ systems (skin, lungs, liver, bone, stomach lining).
2. Gene expression analysis using the Broad Institute Connectivity Map
The authors analysed how GHK-Cu affects human gene expression using the Connectivity Map (CMap) — a massive database developed at MIT and Harvard that maps how compounds alter gene activity. This revealed that GHK-Cu influences 31.2% of all human genes at a threshold of ≥50% expression change — an extraordinarily broad biological effect for a single molecule.
3. Anti-cancer and protective gene data
The gene analysis also revealed that GHK-Cu downregulates 70% of cancer-related genes examined, including metastatic pathways, while upregulating DNA repair and caspase (programmed cell death) genes that eliminate damaged cells.
What Is a Gene Expression Review?
A gene expression review analyses how a compound changes the activity of genes across the entire genome. When a gene is "upregulated," it becomes more active and produces more of its protein product. When it is "downregulated," it becomes less active. By mapping thousands of gene changes simultaneously, researchers can understand the broad biological impact of a compound — not just one effect, but the entire network of changes it triggers.
The Broad Institute Connectivity Map (CMap) used in this review is a gold-standard database created by researchers at MIT and Harvard. It contains gene expression data for thousands of compounds, allowing scientists to compare how GHK-Cu's gene profile matches other known drugs and biological agents. This is particularly powerful because it can reveal mechanisms of action that weren't previously suspected.
Review articles like this one synthesise findings from many individual studies to build a complete picture. While a single study might show that GHK-Cu stimulates collagen, a comprehensive review reveals that it simultaneously activates tissue repair genes, suppresses inflammatory genes, promotes blood vessel growth genes, and resets age-related gene changes — painting a far more complete picture than any single experiment could.
What They Found
31.2% of human genes affected by GHK-Cu
Gene expression analysis revealed that GHK-Cu influences 31.2% of all human genes with a change of ≥50% — an exceptionally broad biological effect. Of the affected genes, 59% were upregulated (made more active) and 41% were downregulated (made less active). This includes 1,569 genes stimulated by 50–99% and 583 genes suppressed by 50–99%.
Collagen synthesis increased up to 70%
Clinical evidence showed that GHK-Cu combined with LED therapy increased collagen synthesis by up to 70% and boosted basic fibroblast growth factor (bFGF) production by 230%. In a controlled clinical trial, 70% of women showed improved skin collagen after thigh treatment — compared to 50% with vitamin C and 40% with retinoic acid.
Natural levels decline 60% with age
GHK-Cu is naturally present in human blood plasma at approximately 200 ng/mL (10⁻⁷ M) at age 20. By age 60, levels drop to approximately 80 ng/mL — a 60% decline. This age-related reduction correlates with decreased tissue repair capacity and is hypothesised to contribute to age-related hair thinning and follicle miniaturisation.
70% of cancer-related genes downregulated
At 1 micromolar concentration, GHK-Cu suppressed metastatic colon cancer gene expression and downregulated 70% of 54 human cancer-related genes examined. Simultaneously, it upregulated 10 caspase genes (which eliminate damaged cells) and activated 84 DNA repair genes — suggesting a powerful cell-protective function.
Tissue repair across multiple organ systems
The review documents GHK-Cu's regenerative effects across skin, lung connective tissue, bone, liver, and stomach lining. It stimulates blood vessel and nerve outgrowth, increases collagen, elastin, and glycosaminoglycan synthesis, and supports the function of dermal fibroblasts — the same cell family as the dermal papilla cells that control hair growth.
GHK-Cu gene expression and biological effects. Data from Pickart & Margolina, International Journal of Molecular Sciences (2018). PMID: 29986520.
How GHK-Cu Works: The Biological Mechanisms
The review reveals that GHK-Cu operates through an unusually wide network of biological pathways:
1. Gene expression reset
GHK-Cu shifts gene expression patterns toward a younger, healthier state. The Broad Institute analysis showed it affects 31.2% of genes — resetting age-related gene changes that contribute to tissue degeneration. For hair, this means reactivating the growth and repair programmes that become less effective with age.
2. Collagen and extracellular matrix remodelling
GHK-Cu stimulates synthesis of collagen, elastin, and glycosaminoglycans — the structural proteins that form the scaffold around hair follicles. As described in our summary of the foundational 2007 Pyo et al. study, copper peptides directly stimulate dermal papilla cells (specialised fibroblasts) to proliferate and resist programmed cell death.
3. Blood vessel and nerve growth stimulation
GHK-Cu promotes VEGF (vascular endothelial growth factor) production, which drives new blood vessel formation around hair follicles. Better blood supply means more nutrients and oxygen reaching the follicle — essential for sustained hair growth. It also stimulates nerve outgrowth, which plays a role in follicle cycling signals.
4. TGF-β1 suppression
The review confirms that GHK-Cu decreases secretion of TGF-β1 by dermal fibroblasts. This is significant because androgen-induced TGF-β1 is a key mediator of hair follicle miniaturisation in androgenetic alopecia — it signals follicular cells to stop growing. By suppressing TGF-β1, GHK-Cu counteracts one of the primary mechanisms of pattern hair loss.
5. Anti-inflammatory and anti-oxidant actions
GHK-Cu suppresses NFκB signalling (a master regulator of inflammation) and reduces oxidative damage. Chronic scalp inflammation is increasingly recognised as a contributing factor to hair loss, particularly in conditions like folliculitis and inflammatory alopecia.
6. Iron chelation and metal regulation
The review documents that GHK-Cu reduces iron release from ferritin by 87%. Excess free iron generates damaging reactive oxygen species. By chelating iron, GHK-Cu provides an additional layer of cellular protection relevant to tissue health.
Clinical Interpretation
Several aspects of this review deserve expert-level analysis:
The gene data explains why GHK-Cu works for so many conditions. Rather than targeting one receptor or one pathway (like most drugs), GHK-Cu orchestrates a coordinated shift in gene expression across 31.2% of the genome. This multi-target mechanism explains why it has documented effects on skin, hair, wounds, lungs, and even cancer gene regulation — something that would be puzzling if it only had one mechanism.
The age-related decline is a key insight for hair loss. GHK-Cu levels drop 60% between age 20 and 60 — the same period during which androgenetic alopecia typically progresses. While correlation does not equal causation, the parallel decline of a regenerative peptide and the onset of hair thinning is biologically plausible and suggests that topical GHK-Cu supplementation could compensate for what the body no longer produces in sufficient quantities.
The collagen data has direct relevance for follicle health. The 70% collagen increase and 230% bFGF increase (with LED) suggest that GHK-Cu could improve the dermal environment around hair follicles. Follicle miniaturisation involves degradation of the surrounding extracellular matrix — strengthening this matrix could slow or partially reverse the process.
The TGF-β1 suppression connects directly to androgenetic alopecia. TGF-β1 is the primary molecular signal through which androgens cause follicle miniaturisation. GHK-Cu's ability to suppress TGF-β1 secretion suggests a mechanism distinct from but complementary to finasteride (which blocks androgen conversion) and minoxidil (which stimulates growth directly).
How This Compares to Other Research
This review builds on and connects to a growing body of copper peptide research:
Pyo, Won, Kim et al. (2007) — This foundational laboratory study demonstrated that the related peptide AHK-Cu directly stimulates hair follicle elongation and protects dermal papilla cells from apoptosis (caspase-3 reduced 42.7%, PARP reduced 77.5%). Pickart and Margolina's review provides the broader gene expression context for why these effects occur.
Lee, Kim et al. (2016) — This clinical trial tested GHK-peptide combined with 5-ALA on actual patients, showing a 7.4× increase in hair count. This study validates in humans what the Pickart review describes at the gene level.
Pamela R.D. (2021) — This placebo-controlled study tested copper tripeptide serum in a double-blind design, providing gold-standard clinical evidence for the topical application that the review's gene data supports.
Kuceki, Wambier et al. (2025) — This recent study combined copper peptides with microneedling, demonstrating 26.5% hair regrowth. The microneedling overcomes the topical delivery challenge that the review identifies — getting GHK-Cu to the dermal papilla cells identified by the gene data as key targets.
Dhurat et al. (2013) — The landmark microneedling study showed that microneedling alone activates many of the same wound-healing pathways (Wnt/β-catenin, VEGF) that GHK-Cu targets through gene expression modulation — suggesting a powerful synergy when combined.
This is a review, not an original clinical trial. The paper synthesises existing research and adds gene expression analysis but does not generate new patient data. The strength of each finding depends on the quality of the original study cited.
Gene expression does not automatically equal clinical effect. While GHK-Cu affects 31.2% of genes, gene expression changes in laboratory conditions do not guarantee the same magnitude of effect in living humans applying a topical product. The gap between gene data and clinical outcomes requires bridging through human trials.
The Connectivity Map has limitations. The Broad Institute CMap provides powerful data but uses specific cell lines and conditions that may not perfectly represent all tissue types. Gene expression patterns in dermal papilla cells specifically have not been mapped in the CMap.
Author affiliation should be noted. Loren Pickart originally discovered GHK-Cu and has been involved in commercialising copper peptide products. While this gives him unique expertise, it is a standard disclosure to note. The review is published in a peer-reviewed journal and the gene data comes from independent databases.
Some cited clinical trials are small. The skin rejuvenation trials cited (41–71 women) are relatively small by modern standards. Hair-specific clinical data within the review is limited; stronger evidence comes from subsequent studies like the 2016 Lee et al. clinical trial.
What This Means For Your Hair
This review connects several important dots for anyone dealing with hair loss:
GHK-Cu is something your body already uses — it's a natural peptide present in your blood, not a synthetic drug. But your body produces 60% less of it by age 60, which coincides with the progression of age-related hair thinning.
It works through multiple pathways simultaneously — unlike finasteride (which blocks one enzyme) or minoxidil (which stimulates growth through one mechanism), GHK-Cu operates across at least six distinct biological pathways: gene expression reset, collagen synthesis, blood vessel growth, TGF-β1 suppression, anti-inflammation, and cell protection. This multi-target approach may explain why copper peptides showed such strong effects in laboratory studies.
It supports the entire follicle environment — not just the hair follicle itself, but the surrounding tissue that provides structural support, nutrients, and growth signals. Improving the dermal environment is a fundamentally different (and complementary) approach to directly stimulating follicle growth.
Topical application and microneedling enhance delivery — research like the 2025 Kuceki study shows that combining GHK-Cu with microneedling (which creates micro-channels in the scalp) dramatically improves delivery to the target cells and produces measurable regrowth.
Key Terms Explained
GHK-Cu (Glycyl-Histidyl-Lysine Copper)
A naturally occurring tripeptide (three amino acids: glycine, histidine, lysine) bound to a copper ion. Found in human blood plasma, it declines with age. Also known as copper peptide-1 or copper tripeptide-1.
Gene expression
The process by which genes are "switched on" to produce proteins. When a compound changes gene expression, it alters which proteins a cell produces — potentially shifting the cell's behaviour toward repair, growth, or protection.
Connectivity Map (CMap)
A database developed at the Broad Institute (MIT/Harvard) that maps how thousands of compounds alter gene activity across the human genome. It allows researchers to compare a compound's gene expression "fingerprint" with known drugs and biological processes.
Collagen
The most abundant structural protein in the body. It forms the scaffolding that gives skin its strength and provides the structural environment around hair follicles. GHK-Cu increases its production by up to 70%.
VEGF (Vascular Endothelial Growth Factor)
A signal protein that stimulates formation of new blood vessels. Hair follicles need robust blood supply for nutrients and oxygen. GHK-Cu promotes VEGF production, improving the vascular network around follicles.
TGF-β1 (Transforming Growth Factor Beta-1)
A protein that, when triggered by androgens, signals hair follicle cells to stop growing — a key mechanism in androgenetic alopecia (pattern baldness). GHK-Cu suppresses TGF-β1 secretion, counteracting this hair loss pathway.
Dermal papilla cells (DPCs)
Specialised fibroblasts at the base of each hair follicle that act as the "command centre" for hair growth. They are the same cell family as dermal fibroblasts — the cells most extensively studied for GHK-Cu's regenerative effects.
NFκB (Nuclear Factor Kappa B)
A master regulator of inflammation. When overactive, it drives chronic inflammation that can damage hair follicles. GHK-Cu suppresses NFκB signalling, providing an anti-inflammatory protective effect.
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
Is GHK-Cu the same as AHK-Cu?
They are related but different copper peptides. GHK-Cu (glycyl-histidyl-lysine-copper) is the most widely studied copper peptide, reviewed in this paper. AHK-Cu (alanyl-histidyl-lysine-copper) has a slightly different amino acid chain but similar biological activity. The 2007 Pyo et al. study demonstrated AHK-Cu's specific effects on hair follicle growth. Many advanced hair formulations include both peptides for complementary benefits.
Does GHK-Cu actually grow hair or just protect against loss?
Both. The gene data in this review shows GHK-Cu activates tissue repair and growth genes while suppressing degradation genes. It also increases collagen and VEGF production (supporting the follicle environment) and suppresses TGF-β1 (blocking a key hair loss signal). The 2016 Lee et al. clinical trial confirmed this dual effect in humans, showing a 7.4× increase in hair count — demonstrating both new growth stimulation and existing hair protection.
Why do GHK-Cu levels decline with age?
GHK-Cu is released from proteins like collagen and SPARC through normal tissue turnover. As we age, the balance shifts from tissue repair toward tissue degradation, and the body produces less GHK-Cu. By age 60, plasma levels are only about 80 ng/mL — down from 200 ng/mL at age 20. This 60% decline correlates with reduced wound healing, skin thinning, and hair follicle miniaturisation.
How does GHK-Cu compare to minoxidil?
They work through different mechanisms. Minoxidil primarily stimulates hair growth by increasing blood flow to follicles and opening potassium channels. GHK-Cu operates through at least six distinct pathways (gene reset, collagen, VEGF, TGF-β1 suppression, anti-inflammation, cell protection). The review suggests their effects may be comparable, and because they use different mechanisms, combining them could provide additive benefits. GHK-Cu has the advantage of being a naturally occurring human peptide with no reported adverse effects.
Can I take GHK-Cu orally for hair growth?
GHK-Cu is a peptide that would be broken down by digestive enzymes if taken orally. Topical application is the standard route for hair and skin use. The review focuses on topical and injectable delivery methods. For hair growth specifically, combining topical GHK-Cu with microneedling is supported by the strongest evidence — as shown in the 2025 Kuceki study which achieved 26.5% regrowth with this combination approach.
Is the 31.2% gene effect safe?
Yes. GHK-Cu is a naturally occurring human peptide, not a synthetic drug — your body already uses it. The gene expression changes documented in this review shift gene activity toward a healthier, younger pattern rather than creating abnormal activity. Additionally, the gene changes include upregulation of cancer-protective genes and DNA repair mechanisms, suggesting a net protective effect. Decades of research have reported no adverse effects from GHK-Cu at therapeutic concentrations.
How long does GHK-Cu take to show results for hair?
The gene expression changes documented in this review occur at the cellular level within hours to days. However, visible hair growth results require multiple hair growth cycles. Based on clinical trials like Lee et al. (2016) and Pamela R.D. (2021), most patients see measurable improvements within 3–6 months of consistent use, with continued improvement up to 12 months.
Is this review biased because Pickart discovered GHK-Cu?
This is a fair question. Loren Pickart's deep involvement with GHK-Cu (from discovery through commercialisation) gives him unique expertise but also represents a potential conflict of interest. However, the review is published in a peer-reviewed journal (International Journal of Molecular Sciences) and the gene expression data comes from the independent Broad Institute Connectivity Map database. The clinical trials cited were conducted by other research groups. The findings are consistent with independent research from groups worldwide.
Original Study Reference
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. doi:10.3390/ijms19071987. PMID: 29986520. PMCID: PMC6073405.
How to Cite This Research Summary
Hairgenetix Research Team. "GHK-Cu: The Science Behind Copper Peptide Hair Regeneration (2018 Review)." Hairgenetix Research Library, March 2026.
Available at: https://hairgenetix.com/blogs/articles/ghk-cu-copper-peptide-regeneration-science-review-2018
Hairgenetix Research Library — We publish plain-language summaries of peer-reviewed clinical studies on hair growth science. Every article links directly to the original published research. Our goal is to make hair loss science accessible, transparent, and evidence-based. Browse all research summaries →
Advanced Daily Scalp Therapy for Stronger, Healthier Hair
🎯 Designed for hair loss and weak, thinning hair 🔬 Clinically Proven Ingredients 💧 Lightweight, non-greasy for easy daily use
The Hairgenetix Copper Peptide Serum is a powerful daily scalp treatment designed to stimulate hair follicles, reduce shedding, and support long-term hair health[2]. Infused with 10% GHK-Cu and 5% AHK-Cu copper peptides, this advanced formula works at the root level to improve follicle longevity, boost collagen production, and enhance scalp circulation[1]—creating the perfect environment for thicker, healthier hair growth.
Professional GHK-Cu Complete Follicle & Scalp Activation System
🚀 Maximizes Hair Growth Support at the Follicle Level 🛡️ Reduces Shedding While Strengthening Hair from Root to Tip 🌿 Optimizes Scalp Health for Thicker, Fuller-Looking Hair
Advanced hair care powered by GHK-Cu & AHK-Cu Copper Peptides. This professional shampoo, conditioner, and serum set works synergistically to cleanse, nourish, and activate the hair follicles at the root. The shampoo gently removes buildup and prepares the scalp, the conditioner restores moisture and resilience, and the targeted serum delivers concentrated copper peptides directly to the follicle environment.[1] Designed to help reduce shedding, improve hair density[2], and create optimal conditions for healthier, thicker-looking hair with consistent use.
Professional GHK-Cu Complete Follicle & Scalp Activation System
🚀 Maximizes Hair Growth Support at the Follicle Level 🛡️ Reduces Shedding While Strengthening Hair from Root to Tip 🌿 Optimizes Scalp Health for Thicker, Fuller-Looking Hair
Advanced hair care powered by GHK-Cu copper peptides. This professional shampoo and conditioner set works synergistically to cleanse, nourish, and strengthen the scalp and hair while supporting follicle regeneration and long-term hair growth.[1] Designed to help reduce shedding, improve hair density[2], and create the optimal environment for healthier, thicker-looking hair with consistent use.
Give the Gift of Science-Backed Hair Growth - Premium Copper Peptide Gift Box
🎁 Premium Gift-Ready Packaging - Complete & Ready to Give
🌟 Larger Sizes for Longer Results - 300ml Shampoo & Conditioner
✨ Complete 3-Step Copper Peptide Hair Care System
Searching for a copper peptide hair growth gift set that genuinely delivers? The Hairgenetix Copper Peptide Gift Box is a complete, research-backed hair care collection presented in premium gift box packaging - ready to give for birthdays, Christmas, or any occasion that deserves something special.
Inside this hair care gift box, you will find generous 300 ml bottles of our GHK-Cu and AHK-Cu infused Copper Peptide Shampoo and Conditioner - larger than the standard set - paired with the 30 ml Copper Peptide Hair Growth Serum. Every product is formulated around two of the most studied peptides in trichology research: GHK-Cu, which supports tissue remodelling and follicle health[2], and AHK-Cu, shown in laboratory studies to stimulate dermal papilla cell proliferation and support hair follicle growth[1].
Copper peptides work by activating the Wnt/beta-catenin signalling pathway in dermal papilla cells - the biological switch that drives the hair growth cycle. Regular use supports thicker-looking hair, a healthier scalp environment, and stronger follicles over time.
Whether you are buying for someone experiencing hair thinning or simply wanting to upgrade their hair care routine, this GHK-Cu gift set is a meaningful choice. Premium ingredients, larger 300 ml sizes, and a complete system - beautifully packaged and ready to make an impact.
🚀 Stimulates Hair Growth at the Follicle Level 🛡️ Reduces Hair Shedding & Strengthens Roots 🌿 Improves Scalp Health for Thicker, Healthier Hair
Advanced hair care powered by GHK-Cu copper peptides. This professional shampoo gently cleanses while supporting scalp regeneration, follicle health, and stronger hair growth.[1] Designed to help reduce shedding, improve hair density[2], and create the optimal environment for healthier, thicker-looking hair with every wash.
Advanced conditioning powered by GHK-Cu copper peptides. This professional conditioner deeply nourishes the hair and scalp while supporting follicle health, strength, and resilience.[1] Designed to reduce breakage, improve hair texture and density[2], and leave hair stronger, smoother, and healthier-looking with every use.
GHK-Cu: The Science Behind Copper Peptide Hair Regeneration (2018 Review)
Research Evidence Summary
Why This Research Matters
GHK-Cu is not just a cosmetic ingredient — it is a naturally occurring molecule in your own body that declines significantly as you age. This 2018 review by Loren Pickart (who originally discovered GHK-Cu in the 1970s) and Anna Margolina brings together decades of research and adds groundbreaking gene expression analysis showing that GHK-Cu affects nearly a third of all human genes.
For hair loss specifically, this matters because GHK-Cu acts on the same biological pathways involved in follicle health: collagen synthesis, blood vessel formation, wound healing, stem cell signalling, and cell survival. Unlike most hair treatments that target a single mechanism, GHK-Cu operates across multiple regenerative systems simultaneously — which is why it has attracted interest from dermatologists, cosmetic chemists, and hair loss researchers worldwide.
This review is also significant because it positions GHK-Cu in the context of gene data from the Broad Institute's Connectivity Map — the same database used by pharmaceutical researchers to discover new drug applications. The gene analysis reveals that GHK-Cu doesn't just treat symptoms; it shifts gene expression patterns toward a younger, healthier state.
What The Researchers Reviewed
Pickart and Margolina conducted a comprehensive review covering three decades of GHK-Cu research. Their analysis included:
1. Historical research on GHK-Cu's biological functions
The review consolidates findings from laboratory studies, animal models, and human clinical trials spanning from the 1980s to 2018. This includes wound healing trials, skin rejuvenation studies, and tissue repair research across multiple organ systems (skin, lungs, liver, bone, stomach lining).
2. Gene expression analysis using the Broad Institute Connectivity Map
The authors analysed how GHK-Cu affects human gene expression using the Connectivity Map (CMap) — a massive database developed at MIT and Harvard that maps how compounds alter gene activity. This revealed that GHK-Cu influences 31.2% of all human genes at a threshold of ≥50% expression change — an extraordinarily broad biological effect for a single molecule.
3. Anti-cancer and protective gene data
The gene analysis also revealed that GHK-Cu downregulates 70% of cancer-related genes examined, including metastatic pathways, while upregulating DNA repair and caspase (programmed cell death) genes that eliminate damaged cells.
What Is a Gene Expression Review?
A gene expression review analyses how a compound changes the activity of genes across the entire genome. When a gene is "upregulated," it becomes more active and produces more of its protein product. When it is "downregulated," it becomes less active. By mapping thousands of gene changes simultaneously, researchers can understand the broad biological impact of a compound — not just one effect, but the entire network of changes it triggers.
The Broad Institute Connectivity Map (CMap) used in this review is a gold-standard database created by researchers at MIT and Harvard. It contains gene expression data for thousands of compounds, allowing scientists to compare how GHK-Cu's gene profile matches other known drugs and biological agents. This is particularly powerful because it can reveal mechanisms of action that weren't previously suspected.
Review articles like this one synthesise findings from many individual studies to build a complete picture. While a single study might show that GHK-Cu stimulates collagen, a comprehensive review reveals that it simultaneously activates tissue repair genes, suppresses inflammatory genes, promotes blood vessel growth genes, and resets age-related gene changes — painting a far more complete picture than any single experiment could.
What They Found
Gene expression analysis revealed that GHK-Cu influences 31.2% of all human genes with a change of ≥50% — an exceptionally broad biological effect. Of the affected genes, 59% were upregulated (made more active) and 41% were downregulated (made less active). This includes 1,569 genes stimulated by 50–99% and 583 genes suppressed by 50–99%.
Clinical evidence showed that GHK-Cu combined with LED therapy increased collagen synthesis by up to 70% and boosted basic fibroblast growth factor (bFGF) production by 230%. In a controlled clinical trial, 70% of women showed improved skin collagen after thigh treatment — compared to 50% with vitamin C and 40% with retinoic acid.
GHK-Cu is naturally present in human blood plasma at approximately 200 ng/mL (10⁻⁷ M) at age 20. By age 60, levels drop to approximately 80 ng/mL — a 60% decline. This age-related reduction correlates with decreased tissue repair capacity and is hypothesised to contribute to age-related hair thinning and follicle miniaturisation.
At 1 micromolar concentration, GHK-Cu suppressed metastatic colon cancer gene expression and downregulated 70% of 54 human cancer-related genes examined. Simultaneously, it upregulated 10 caspase genes (which eliminate damaged cells) and activated 84 DNA repair genes — suggesting a powerful cell-protective function.
The review documents GHK-Cu's regenerative effects across skin, lung connective tissue, bone, liver, and stomach lining. It stimulates blood vessel and nerve outgrowth, increases collagen, elastin, and glycosaminoglycan synthesis, and supports the function of dermal fibroblasts — the same cell family as the dermal papilla cells that control hair growth.
How GHK-Cu Works: The Biological Mechanisms
The review reveals that GHK-Cu operates through an unusually wide network of biological pathways:
1. Gene expression reset
GHK-Cu shifts gene expression patterns toward a younger, healthier state. The Broad Institute analysis showed it affects 31.2% of genes — resetting age-related gene changes that contribute to tissue degeneration. For hair, this means reactivating the growth and repair programmes that become less effective with age.
2. Collagen and extracellular matrix remodelling
GHK-Cu stimulates synthesis of collagen, elastin, and glycosaminoglycans — the structural proteins that form the scaffold around hair follicles. As described in our summary of the foundational 2007 Pyo et al. study, copper peptides directly stimulate dermal papilla cells (specialised fibroblasts) to proliferate and resist programmed cell death.
3. Blood vessel and nerve growth stimulation
GHK-Cu promotes VEGF (vascular endothelial growth factor) production, which drives new blood vessel formation around hair follicles. Better blood supply means more nutrients and oxygen reaching the follicle — essential for sustained hair growth. It also stimulates nerve outgrowth, which plays a role in follicle cycling signals.
4. TGF-β1 suppression
The review confirms that GHK-Cu decreases secretion of TGF-β1 by dermal fibroblasts. This is significant because androgen-induced TGF-β1 is a key mediator of hair follicle miniaturisation in androgenetic alopecia — it signals follicular cells to stop growing. By suppressing TGF-β1, GHK-Cu counteracts one of the primary mechanisms of pattern hair loss.
5. Anti-inflammatory and anti-oxidant actions
GHK-Cu suppresses NFκB signalling (a master regulator of inflammation) and reduces oxidative damage. Chronic scalp inflammation is increasingly recognised as a contributing factor to hair loss, particularly in conditions like folliculitis and inflammatory alopecia.
6. Iron chelation and metal regulation
The review documents that GHK-Cu reduces iron release from ferritin by 87%. Excess free iron generates damaging reactive oxygen species. By chelating iron, GHK-Cu provides an additional layer of cellular protection relevant to tissue health.
Clinical Interpretation
Several aspects of this review deserve expert-level analysis:
How This Compares to Other Research
This review builds on and connects to a growing body of copper peptide research:
GHK-Cu Properties and Biological Data
Research Limitations
What This Means For Your Hair
This review connects several important dots for anyone dealing with hair loss:
Key Terms Explained
Further Reading
For more peer-reviewed studies on hair loss and copper peptide therapy, see our full research hub.
Frequently Asked Questions
Is GHK-Cu the same as AHK-Cu?
They are related but different copper peptides. GHK-Cu (glycyl-histidyl-lysine-copper) is the most widely studied copper peptide, reviewed in this paper. AHK-Cu (alanyl-histidyl-lysine-copper) has a slightly different amino acid chain but similar biological activity. The 2007 Pyo et al. study demonstrated AHK-Cu's specific effects on hair follicle growth. Many advanced hair formulations include both peptides for complementary benefits.
Does GHK-Cu actually grow hair or just protect against loss?
Both. The gene data in this review shows GHK-Cu activates tissue repair and growth genes while suppressing degradation genes. It also increases collagen and VEGF production (supporting the follicle environment) and suppresses TGF-β1 (blocking a key hair loss signal). The 2016 Lee et al. clinical trial confirmed this dual effect in humans, showing a 7.4× increase in hair count — demonstrating both new growth stimulation and existing hair protection.
Why do GHK-Cu levels decline with age?
GHK-Cu is released from proteins like collagen and SPARC through normal tissue turnover. As we age, the balance shifts from tissue repair toward tissue degradation, and the body produces less GHK-Cu. By age 60, plasma levels are only about 80 ng/mL — down from 200 ng/mL at age 20. This 60% decline correlates with reduced wound healing, skin thinning, and hair follicle miniaturisation.
How does GHK-Cu compare to minoxidil?
They work through different mechanisms. Minoxidil primarily stimulates hair growth by increasing blood flow to follicles and opening potassium channels. GHK-Cu operates through at least six distinct pathways (gene reset, collagen, VEGF, TGF-β1 suppression, anti-inflammation, cell protection). The review suggests their effects may be comparable, and because they use different mechanisms, combining them could provide additive benefits. GHK-Cu has the advantage of being a naturally occurring human peptide with no reported adverse effects.
Can I take GHK-Cu orally for hair growth?
GHK-Cu is a peptide that would be broken down by digestive enzymes if taken orally. Topical application is the standard route for hair and skin use. The review focuses on topical and injectable delivery methods. For hair growth specifically, combining topical GHK-Cu with microneedling is supported by the strongest evidence — as shown in the 2025 Kuceki study which achieved 26.5% regrowth with this combination approach.
Is the 31.2% gene effect safe?
Yes. GHK-Cu is a naturally occurring human peptide, not a synthetic drug — your body already uses it. The gene expression changes documented in this review shift gene activity toward a healthier, younger pattern rather than creating abnormal activity. Additionally, the gene changes include upregulation of cancer-protective genes and DNA repair mechanisms, suggesting a net protective effect. Decades of research have reported no adverse effects from GHK-Cu at therapeutic concentrations.
How long does GHK-Cu take to show results for hair?
The gene expression changes documented in this review occur at the cellular level within hours to days. However, visible hair growth results require multiple hair growth cycles. Based on clinical trials like Lee et al. (2016) and Pamela R.D. (2021), most patients see measurable improvements within 3–6 months of consistent use, with continued improvement up to 12 months.
Is this review biased because Pickart discovered GHK-Cu?
This is a fair question. Loren Pickart's deep involvement with GHK-Cu (from discovery through commercialisation) gives him unique expertise but also represents a potential conflict of interest. However, the review is published in a peer-reviewed journal (International Journal of Molecular Sciences) and the gene expression data comes from the independent Broad Institute Connectivity Map database. The clinical trials cited were conducted by other research groups. The findings are consistent with independent research from groups worldwide.
How to Cite This Research Summary
Hairgenetix Research Team. "GHK-Cu: The Science Behind Copper Peptide Hair Regeneration (2018 Review)." Hairgenetix Research Library, March 2026.
Available at: https://hairgenetix.com/blogs/articles/ghk-cu-copper-peptide-regeneration-science-review-2018
Related Research on Hairgenetix